Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine

Erstveröffentlichung

2019

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Schlenk, Richard Friedrich

Weber, Daniela

Herr, Wolfgang

Wulf, Gerald

Salih, Helmut R.

et al.

Institutions

UKU. Klinik für Innere Medizin III

Published in

Leukemia ; 33 (2019), 8. - S. 1923-1933. - ISSN 0887-6924. - eISSN 1476-5551

Link to publication

https://dx.doi.org/10.1038/s41375-019-0395-y

Funding information

Celgene GmbH

Dewey Decimal Group

DDC 610 / Medicine & health

---

Metadata

Show full item record